Search - Inserm - Institut national de la santé et de la recherche médicale Access content directly

Filter your results

25 Results
Author: personID (integer) : 760785

Place du pathologiste dans la prise en charge du carcinome rénal en situation néoadjuvante. [The pathologist's role in the neoadjuvant strategy of renal-cell carcinoma].

Xavier Leroy , Julien Edeline , Nathalie Rioux-Leclercq
Annales de Pathologie, 2011, 31 (6), pp.466-71. ⟨10.1016/j.annpat.2011.10.004⟩
Journal articles inserm-00653252v1
Image document

Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy

Corentin Louis , Julien Edeline , Cédric Coulouarn
Expert Opinion on Therapeutic Targets, 2021, 25 (2), pp.153-162. ⟨10.1080/14728222.2021.1882998⟩
Journal articles hal-03129158v1
Image document

Carcinomes à cellules rénales et facteurs pronostiques. [Renal cell carcinoma and prognostic factors]

Julien Edeline , Nathalie Rioux-Leclercq
Annales de Pathologie, 2008, 28 (5), pp.374-80. ⟨10.1016/j.annpat.2008.06.031⟩
Journal articles inserm-00354469v1
Image document

Evolution of parenteral nutrition practices in a comprehensive cancer center: Comparative audits

Alexandre Peinoit , Léa Muzellec , Mickaël Som , Julien Edeline , Ronan Thibault , et al.
Bulletin du Cancer, 2023, ⟨10.1016/j.bulcan.2023.02.021⟩
Journal articles hal-04061903v1
Image document

Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential

Solène-Florence Kammerer-Jacquet , Laurence Crouzet , Angélique Brunot , Julien Dagher , Adélaide Pladys , et al.
International Journal of Cancer, 2017, 140 (1), pp.142-148. ⟨10.1002/ijc.30429⟩
Journal articles hal-01439352v1
Image document

Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial

Julien Edeline , Yann Touchefeu , Boris Guiu , Olivier Farge , David Tougeron , et al.
JAMA oncology, 2020, 6 (1), pp.51. ⟨10.1001/jamaoncol.2019.3702⟩
Journal articles hal-02364095v1
Image document

Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma

Gaëlle Angenard , Aude Merdrignac , Corentin Louis , Julien Edeline , Cédric Coulouarn
Digestive and Liver Disease, 2019, 51 (9), pp.1337-1343. ⟨10.1016/j.dld.2019.03.019⟩
Journal articles hal-02152868v1
Image document

Integrative genomics highlights opportunities for innovative therapies targeting the tumor microenvironment in gallbladder cancer

Stephanie Roessler , Julien Edeline , Peter Schirmacher , Cédric Coulouarn
Journal of Hepatology, 2021, 74 (5), pp.1018-1020. ⟨10.1016/j.jhep.2020.12.024⟩
Journal articles hal-03156698v1
Image document

Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective study

Juliette Viaud , Clémence Brac , Pascal Artru , Estelle Le Pabic , Bérengère Leconte , et al.
Digestive and Liver Disease, 2017, 49 (6), pp.692-696. ⟨10.1016/j.dld.2017.02.007⟩
Journal articles hal-01534249v1

La neutrophil gelatinase-associated lipocalin, ou LCN 2, facteur d'agressivité dans le carcinome rénal à cellules claires (CRCC). [The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma].

Christophe Perrin , Jean-Jacques Patard , Florence Jouan , Nicolas Collet , Sandrine Théoleyre , et al.
Progrès en Urologie, 2011, 21 (12), pp.851-8. ⟨10.1016/j.purol.2011.06.005⟩
Journal articles inserm-00638985v1
Image document

High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with (90) Y-loaded glass microsphere radioembolization

Etienne Garin , Yan Rolland , Marc Pracht , Samuel Le Sourd , Sophie Laffont , et al.
Liver International, 2017, 37 (1), pp.101-110. ⟨10.1111/liv.13220⟩
Journal articles hal-01447063v1
Image document

Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role.

Stefania de Lorenzo , Francesco Tovoli , Alessandro Mazzotta , Francesco Vasuri , Julien Edeline , et al.
Cancers, 2020, 12 (11), pp.E3182. ⟨10.3390/cancers12113182⟩
Journal articles hal-02998325v1
Image document

Lobar hepatocellular carcinoma with ipsilateral portal vein tumor thrombosis treated with yttrium-90 glass microsphere radioembolization: preliminary results.

Marc Pracht , Julien Edeline , Laurence Lenoir , M. Latournerie , Habiba Mesbah , et al.
International Journal of Hepatology, 2013, 2013, pp.827649. ⟨10.1155/2013/827649⟩
Journal articles inserm-00814189v1
Image document

Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT)

Luc Beuzit , Julien Edeline , Vanessa Brun , Maxime Ronot , Anne Guillygomarc'H , et al.
European Journal of Radiology, 2016, 85 (8), pp.1445--1452. ⟨10.1016/j.ejrad.2016.05.020⟩
Journal articles hal-01363197v1

Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma.

Julien Edeline , Brigitte Laguerre , Yan Rolland , Jean-Jacques Patard
Annals of Oncology, 2010, 21 (1), pp.186-7. ⟨10.1093/annonc/mdp480⟩
Journal articles inserm-00432304v1
Image document

FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma

Antonin Vary , Loïc Lebellec , Frédéric Di Fiore , Nicolas Penel , Claire Cheymol , et al.
Therapeutic Advances in Medical Oncology, 2021, 13, pp.17588359211029825. ⟨10.1177/17588359211029825⟩
Journal articles hal-03367978v2
Image document

Biomarqueurs prédictifs de réponse aux inhibiteurs de points de contrôle immuns

Alexandra Frelau , Marc Pracht , Samuel Le Sourd , Alexandra Lespagnol , Romain Corre , et al.
Bulletin du Cancer, 2018, ⟨10.1016/j.bulcan.2017.10.031⟩
Journal articles hal-01815717v1
Image document

FOLFIRINOX De-Escalationin Advanced Pancreatic Cancer: A MulticenterReal-LifeStudy

Hortense Chevalier , Angélique Vienot , Astrid Lièvre , Julien Edeline , Farid El Hajbi , et al.
Oncologist, 2020, 25 (11), pp.e1701-e1710. ⟨10.1634/theoncologist.2020-0577⟩
Journal articles hal-02958602v1
Image document

Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma

Xavier Palard , Julien Edeline , Yan Rolland , Samuel Le Sourd , Marc Pracht , et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 (3), pp.392-401. ⟨10.1007/s00259-017-3845-7⟩
Journal articles hal-01709935v1
Image document

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial

Etienne Garin , Lambros Tselikas , Boris Guiu , Julia Chalaye , Julien Edeline , et al.
The Lancet Gastroenterology & Hepatology, 2021, 6 (1), pp.17-29. ⟨10.1016/S2468-1253(20)30290-9⟩
Journal articles hal-02998830v1

Adverse events of targeted therapies reported by patients with cancer treated in primary care

Emilie Roger , Julien Edeline , Boris Campillo-Gimenez , Elodie Ventroux , Marie-Eve Rouge-Bugat , et al.
European Journal of General Practice, 2020, 26 (1), pp.202-209. ⟨10.1080/13814788.2020.1846713⟩
Journal articles hal-03127093v1
Image document

CAR-T cells and BiTEs in solid tumors: challenges and perspectives

Julien Edeline , Roch Houot , Aurélien Marabelle , Marion Alcantara
Journal of Hematology and Oncology, 2021, 14 (1), pp.65. ⟨10.1186/s13045-021-01067-5⟩
Journal articles hal-03228682v1
Image document

Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres

Etienne Garin , Yan Rolland , Sophie Laffont , Julien Edeline
European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 (3), pp.559-575. ⟨10.1007/s00259-015-3157-8⟩
Journal articles hal-01197349v1
Image document

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan

Lorenzo Fornaro , Francesco Leone , Angélique Vienot , Andrea Casadei-Gardini , Caterina Vivaldi , et al.
Clinical Colorectal Cancer, 2019, 18 (4), pp.e394-e401. ⟨10.1016/j.clcc.2019.08.004⟩
Journal articles hal-02307162v1
Image document

Voies moléculaires dans le cancer du rein : de la biologie aux traitements de demain. [Signalling pathways in renal-cell carcinoma: from the molecular biology to the future therapy]

Julien Edeline , Cécile Vigneau , Jean-Jacques Patard , Nathalie Rioux-Leclercq
Bulletin du Cancer, 2010, 97, pp.5-15. ⟨10.1684/bdc.2010.1066⟩
Journal articles inserm-00480057v1